Pharma reverse logistics is the most regulated part of the supply chain and the most underinvested. Returns, recalls, expired-product pulls, and destruction chains demand the same controls as outbound dispatch — custody, temperature history, lot traceability, documented destruction — but are usually run on manual workflows and email approvals. Shipsy’s pharma clients have moved reverse flows onto the same audit-grade substrate as forward flows, closing the dominant source of pharma compliance findings.
The finding: reverse is where audit findings hide
Most pharma networks run forward logistics on modern systems and reverse logistics on legacy processes. The audit consequence shows up immediately: 483 letters frequently cite inadequate return handling, unclear destruction evidence, missing custody records for recalled product, and poorly segregated quarantined inventory.
These are not process failures — they are system failures. Reverse flows need the same transaction-level audit trail, lot traceability, and e-signature workflows that forward flows have. Running them on a spreadsheet or a help-desk queue is what creates the gaps.
Why pharma reverse logistics is hard
Three reasons.
Provenance uncertainty. A product arriving into a returns bay may have been out of regulated storage for days. Its fitness for redistribution depends on a temperature history the returner rarely has. Default policy: quarantine. But the system has to know that.
Destruction accountability. Destruction of regulated pharma has its own compliance framework — documented, witnessed, with chain of custody from quarantine through to incineration. The evidence has to be retrievable on demand.
Recall speed. In a recall event, every unit of the affected lot has to be located across depots, pharmacies, and in some cases consignees. The time-to-identify and time-to-retrieve metrics are regulator-reported. Slow recall = escalation.
What Shipsy does for pharma reverse logistics
Shipsy’s reverse flow uses four mechanisms, all shared with forward flow’s system of record.
Reverse WMS workflow with quarantine-first logic. Returned product enters Shipsy’s WMS into a quarantined bin by default. Release to sellable stock requires QA sign-off with documented temperature and custody history. Non-verifiable returns route automatically to destruction queue.
Lot traceability across forward and reverse. The same lot traceability backbone that powers forward flows (inbound, storage, outbound, consignee) tracks reverse events — return receipt, QA disposition, destruction. One query returns the full lifecycle for any lot.
Destruction chain with documented custody via Atlas. Atlas — Shipsy’s autonomous control tower — orchestrates destruction workflows: pickup from quarantine, transport to destruction facility, witness sign-offs, destruction certificate capture. Every step is an immutable audit record.
Recall execution at network speed. On a recall trigger, the WMS locates every unit of the affected lot across the network in one query, generates pull lists per depot and pharmacy, and executes reverse shipment orchestration. Clara — Shipsy’s CX agent — coordinates consignee notifications.
Pharma reverse workflow control map
| Reverse event | Shipsy mechanism | Audit artefact |
|---|---|---|
| Customer return from pharmacy | Quarantine-first WMS bin + QA workflow | Disposition record with custody evidence |
| Expired product pull from depot | Scheduled reverse dispatch + lot sweep | Lot-complete pull report |
| Voluntary recall (Class I/II/III) | Lot-level network sweep + reverse orchestration | Recall execution timeline |
| Destruction of non-releasable product | Atlas destruction workflow + witness sign-off | Destruction certificate + chain of custody |
| Consignee-initiated return | Reverse pickup via driver app + cold-kit logging | ePOD reverse + condition record |
What pharma ops leaders should do in the next 90 days
Audit your reverse logistics audit trail. For the last six months of returns, can you produce a documented disposition trail per unit? If the answer requires email archaeology, you have an audit liability waiting for an inspection.
Next, time a recall drill. Pick a lot that is live in your network and measure how long it takes to locate every unit, generate pull lists, and confirm receipt at your recall aggregation point. Anything over 48 hours should be your top priority.
Finally, move destruction chain onto a single system. Most pharma networks still run destruction on paper certificates and witness signatures stored in folders. A digitised destruction chain closes the most common audit finding in pharma reverse.
For the complementary WMS story, see 21 CFR, GDP, GMP compliant warehousing. For the pharma vertical story, see how Shipsy fits pharma. For the underlying product, see Shipsy WMS.